📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. (2017)

First Author: Arce Vargas F

Attributed to: MICA: Immunotherapy for oral cancer prevention and treatment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2017.03.013

PubMed Identifier: 28410988

Publication URI: http://europepmc.org/abstract/MED/28410988

Type: Journal Article/Review

Volume: 46

Parent Publication: Immunity

Issue: 4

ISSN: 1074-7613